Researchers at Indiana University School of Medicine are examining the brains of individuals with asymptomatic Alzheimer’s disease who, despite having amyloid plaque and tau buildup—the primary indicators of Alzheimer’s—did not show diagnosable dementia symptoms while alive. They’ve identified crucial mechanisms that may safeguard against cognitive decline in Alzheimer’s disease.
This article was originally published on MedicalXpress.com